Antitrust police raid Sanofi's Hungarian HQ; Glaxo nabs FDA approval for OTC Flonase;

> Hungary's competition watchdog raided Sanofi's ($SNY) domestic headquarters as part of a probe into its wholesaler-selection practices. Report

> The FDA approved an over-the-counter version of Flonase, the allergy-fighting nasal spray from GlaxoSmithKline ($GSK); a launch is planned for next year. Report

> GlaxoSmithKline ($GSK) rolled out its once-weekly Type 2 diabetes treatment Tanzeum (albiglutide), a GLP-1 agonist, in the U.S. Release

> Ranbaxy Laboratories signed up to market Cipher Pharmaceuticals' acne drug Absorica (irotretinoin) in Brazil. Report

> CANbridge Life Sciences inked a marketing partnership with Jazz Pharmaceuticals ($JAZZ) to commercialize the oral mucositis treatment Caphosol in China. Release

> Novo Nordisk ($NVO) signed on to help feed needy families in Egypt during the holy month of Ramadan. Report

> Bayer and Amgen ($AMGN) said their cancer drug Nexavar failed to hit its primary endpoint in another Phase III breast cancer study. Report

And Finally... Want a custom bobblehead for your promo campaign? Amazon now has a 3D printing store. Report

Suggested Articles

Trodelvy
Marketing

Trodelvy could net $4.7B in breast cancer sales alone: analyst

An oncologist leader RBC Capital Markets interviewed expressed comfort that Trodelvy will succeed in earlier-line TNBC and in HR-positive disease.

by Angus Liu
coronavirus test tubes
Marketing

Pharma's reputation gains persist through pandemic, poll says

COVID-19 vaccine makers' recent safety pledge continues to increase positive sentiment among Americans, new Harris Poll data say.

by Beth Snyder Bulik
Zolgensma
Marketing

Novartis hits FDA roadblock in Zolgensma expansion bid

Rather than accept a filing based on phase 1/2 data, the FDA wants Novartis to run a phase 3 for a market-expanding version of gene therapy Zolgensma.

by Angus Liu